sapogenins - CISMeF

Preferred Label : sapogenins;

MeSH definition : The aglucon moiety of a saponin molecule. It may be triterpenoid or steroid, usually spirostan, in nature.;

Wikipedia link : https://en.wikipedia.org/wiki/Sapogenins;

Is substance : O;

Details

Origin ID

D012502;

UMLS CUI

C0036188;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Indexing information
- 21-nor-18,27-dimethyl-1,2,3-trihydroxy-25-spirost-4-en-19-oic acid [MeSH Supplementary Concept]
- dihydromarthasterone [MeSH Supplementary Concept]
- epismilagenin glucuronide [MeSH Supplementary Concept]
- rockogenin [MeSH Supplementary Concept]
- ruscogenin [MeSH Supplementary Concept]
- sarsasapogenin [MeSH Supplementary Concept]
- sarsasapogenone [MeSH Supplementary Concept]
Record concept(s)
- sapogenins [MeSH concept]
Related MeSH Supplementary Concept(s)
- 20-O-(beta-D-glucopyranosyl)-20(S)-protopanaxadiol [MeSH Supplementary Concept]
- 20-methoxyldammarane-3,12,25-triol [MeSH Supplementary Concept]
- 22-O-angeloyl theasapogenol E [MeSH Supplementary Concept]
- 23-oxotigogenin acetate [MeSH Supplementary Concept]
- 25-methoxyldammarane-3,12,20-triol [MeSH Supplementary Concept]
- 3,20,21-trihydroxydammar-24-ene [MeSH Supplementary Concept]
- atroviolacegenin [MeSH Supplementary Concept]
- atroviolaceoside [MeSH Supplementary Concept]
- caulophyllogenin [MeSH Supplementary Concept]
- cycloastragenol [MeSH Supplementary Concept]
- cyclocanthogenol [MeSH Supplementary Concept]
- esculeogenin B [MeSH Supplementary Concept]
- esculeoside A [MeSH Supplementary Concept]
- ginsenoside 20S-protopanaxatriol [MeSH Supplementary Concept]
- glyyunnanprosapogenin D [MeSH Supplementary Concept]
- glyyunnansapogenin A [MeSH Supplementary Concept]
- glyyunnansapogenin B [MeSH Supplementary Concept]
- glyyunnansapogenin F [MeSH Supplementary Concept]
- hecogenin [MeSH Supplementary Concept]
- holostanol [MeSH Supplementary Concept]
- holotoxinogenin [MeSH Supplementary Concept]
- isoesculeogenin A [MeSH Supplementary Concept]
- muzanzagenin [MeSH Supplementary Concept]
- namogenin A [MeSH Supplementary Concept]
- namogenin B [MeSH Supplementary Concept]
- namogenin C [MeSH Supplementary Concept]
- porrigenin A [MeSH Supplementary Concept]
- porrigenin B [MeSH Supplementary Concept]
- prosaikogenin A [MeSH Supplementary Concept]
- protopanaxadiol [MeSH Supplementary Concept]
- protopanaxatriol [MeSH Supplementary Concept]
- saikogenin F [MeSH Supplementary Concept]
- tupichigenin A [MeSH Supplementary Concept]
- tupichigenin B [MeSH Supplementary Concept]
- tupichigenin C [MeSH Supplementary Concept]
- umbilicagenin A [MeSH Supplementary Concept]
- umbilicagenin B [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients